MTT Test and Time-lapse Microscopy to Evaluate the Antitumor Potential of Nucleoside Analogues

Alexandra Kiss1, ViktÓria Baksa1, MiklÓs Bege2,3

  • 1Department of Molecular Biotechnology and Microbiology, University of Debrecen, Debrecen, Hungary.

Anticancer Research
|January 9, 2021
PubMed
Abstract

Insights

This study introduces a live-cell microscopy method combined with MTT assays to analyze anticancer drug effects. The technique offers deeper insights into cellular mechanisms and drug responses than conventional viability tests.

Area of Science:

  • Cell biology
  • Pharmacology
  • Microscopy

Background:

  • Conventional viability tests offer limited molecular insight into drug effects.
  • There is a need for advanced methods to analyze cellular responses to potential anticancer agents.

Purpose of the Study:

  • To develop and validate a live-cell microscopy method for in-depth analysis of anticancer drug mechanisms.
  • To compare the efficacy of a novel nucleoside analogue with a known one.

Main Methods:

  • Combining MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay with time-lapse scanning microscopy (TLS).
  • Utilizing image analysis for quantitative assessment of cellular morphology and cell-cycle dynamics.
  • Detecting apoptotic and necrotic events.

Main Results:

  • The TLS method provides dynamic data on cell morphology and cell-cycle progression.
  • Apoptotic and necrotic cell death pathways were identified.
  • Comparative in vitro analysis of a novel nucleoside analogue against a known one was performed.

Conclusions:

  • The proposed TLS-MTT approach offers superior insight into cellular processes affected by chemotherapeutics.
  • This method enhances the understanding of nucleoside analogues' effects compared to traditional assays.

Related Concept Videos